Results 91 to 100 of about 2,027 (134)

Adenylate cyclase 9 expression level is associated with hormone receptor-positive breast cancer and predicts patient prognosis. [PDF]

Nagoya J Med Sci
Sugino K, Shibata M, Adachi Y, Soeda I, Ichikawa T, Inaishi T, Kanaya E, Kanda M, Hayashi M, Masuda N.   +9 more
europepmc   +1 more source

OZ-001 Suppresses the Growth of Triple-Negative Breast Cancer and Pancreatic Cancer by Targeting STAT3 Phosphorylation and the Calcium Signaling Pathway. [PDF]

Biomol Ther (Seoul)
Kim J, Kim HK, Lee S, Yu YJ, Ullah A, Kim EY, Yoo H, Chae HJ.   +7 more
europepmc   +1 more source

Sleepyhead, deadly awakening: the dynamics of metastatic organotropism, tumor dormancy and therapeutic implications. [PDF]

Front Oncol
Sarkar S, P K S.
europepmc   +1 more source

Significance of expression in claudin-low breast cancer and crosstalk with the nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) pathway [PDF]

core   +1 more source

Cilengitide sensitivity is predicted by overall integrin expression in breast cancer. [PDF]

Breast Cancer Res
Girnius N, Henstridge AZ, Marks B, Yu JK, Gray GK, Sander C, Zervantonakis IK, Luna A.   +7 more
europepmc   +1 more source

The ISGylation tapestry in cancer: weaving phenotypic plasticity through multidimensional regulatory looms. [PDF]

Cell Mol Biol Lett
Wu R, Shao F, Koh SB, Okoli UA, Li D, Wang J, Tuo Z, Zhang R, Wusiman D, Cheema U, Kong D, Feng D.   +11 more
europepmc   +1 more source

Targeting ENO1 reprograms macrophage polarization to trigger antitumor immunity and improves the therapeutic effect of radiotherapy. [PDF]

Cell Death Dis
Lin YS, Chang HY, Hong WZ, Chen JY, Huang WC, Yuan TT, Ke TW, Tsai YY, Chen TH, Liang JA, Chao JI, Chao KSC, Huang KC.   +12 more
europepmc   +1 more source

Differential AXL expression and Arf1 regulation control stiffness-dependent Golgi organization in breast cancer cells. [PDF]

J Cell Sci
Saha A, Sherkhane T, Balasubramanian N.
europepmc   +1 more source

Cell morphology best predicts tumorigenicity and metastasis in vivo across multiple TNBC cell lines of different metastatic potential. [PDF]

Breast Cancer Res
Conner SJ, Guarin JR, Le TT, Fatherree JP, Kelley C, Payne SL, Parker SR, Bloomer H, Zhang C, Salhany K, McGinn RA, Henrich E, Yui A, Srinivasan D, Borges H, Oudin MJ.   +15 more
europepmc   +1 more source

A review of the participation of DDIT4 in the tumor immune microenvironment through inhibiting PI3K-Akt/mTOR pathway. [PDF]

Front Oncol
Jiao Y, Xiang Y.
europepmc   +1 more source